Vol. 35 (1987) ddy mice weighing 15-20 g were injected intravenously with 5% PSB (0.1 m1/10 g body weight). Immediately after the injection, the left ear was pinched for 5 s between two felt pads which had been soaked in xylene beforehand. Fifteen minutes later, both ears were removed and placed between two plates (10 x 45 mm), each of which had a hole (6 mm diameter) in its center. The plates were then placed in the cuvette and the optical density value of the bluish color in the left ear was measured at 630 nm (the right ear was used as a blank). The dye concentration wascalculated from the calibration curve and expressed as PSB concentration. One hour prior to the stimulation, a test sample to be tested was administered orally to the mouse. Capillary Permeability Test Induced by Various Phlogists in Rat Skin According to the methods of Thomas and West,4) and Crunkhorn and Willis,' male SD rats weighing 150-180 g were fasted and had their backs shaved 24 h prior to experiments, but were supplied with water ad libitum. Histamine, serotonin, btadykinin, PG E2 and compound 48/80 solutions were prepared at 1 mg/ml, 100, 50, 10 pg/m1 and 1 mg/ml, respectively. Each phlogist (0.1 ml) and saline (0.1 ml) were administered intradermally at two points in the left and right back, respectively. Immediately, the rats were injected intravenously with 0.5% PSB (1 ml/kg). Forty-five minutes later, the rats were killed and skinned. The capillary permeability was expressed by multiplying the major and minor axes of theblue areas caused by the phlogist. A test sample was administered orally 1 h prior to the injection of each phlogist.
Ultraviolet Erythema Method The procedure employed was basically that of Winder et al. Male guinea pigs of Hartley strain weighing 250-350 g were used. Their backs were shaved 24 h prior to experiments by using a depilation mixture. A piece of felt with 3 holes (each 1 cm diameter) was used. The ultraviolet lamp (Wako Denki Rikagaku Co.) was used at a distance of 17 cm and the exposure time was 60 s, as described by Fujimura etal.') The erythema was evaluated by the method of Higuchi et a1.8' An exposed spot which develops no evident erythema scores 0.0, while one with a full circle of definite redness of any intensity scores 3.0. A spot with clear erythema over only a part of the spot scores 2.0, and one with the only slight and partial redness scores 1.0. The erythema was scored at 2 and 5 h after the ultraviolet exposure. The sample was administered intraperitoneally 1 h prior to the ultraviolet exposure.
Anti-inflammatory Activity Test Using CMC Pouch Method According to the method described by Ishikawa and Mori,9' 5 ml of N2 gas was injected subcutaneously to the backs of male rats weighing 130-150 g one day before the injection of 5 ml of 2% CMC suspension in 0.9% NaC1 into the N2 gas sac. For the measurement of leucocyte number and protein content in the CMC fluid, 0.2 ml of the pouch fluid was collected in a tuberculin syringe 2, 4 and 6 h after the CMC injection. Leucocytes from 0.1 ml of the pouch fluid were stained with 0.05% brilliant cresyl blue in saline and were counted with a hemocytometer. The remaining pouch fluid (0.1 ml) was used for the determination of protein concentration using Folin-Lowry's method. A test sample was administered orally 1 h prior to the CMC injection.
Felt Pellet-Induced Granuloma The basic procedUre was as reported by Robert and tezamic,10) and Nakamura and Shimizu." Eight male rats of SD strain, weighing 150-200 g were used for each group. Felt pellets, weighing 35 + 1 mg (0.5-0.6 cm in diameter) each, were prepared from a felt pellets 0.6 cm thick and sterilized in an autoclave for 30 min at 120 °C. Two felt pellets were implanted into the subcutaneous space of the scapular region under pentobarbital anesthesia. On the 8th day after implantation, felt pellets, along with the surrounding inflammatory tissue, were removed from the animals. The removed granulomas were dried at 60 °C until theyreached constant weight. The net weight increase was determined by subtracting the original weight of the felt pellet.
Adrenal glands, thyinus, spleen, kidney and liver were also weighed immediately after the incision and were expressed as the weight per 100 g body weight. Test samples were orally administered at 24-h intervals for 8d.
Croton Oil Granuloma Pouch The procedure employed was basically that of Selye,") Itoga and Miyake.13) Male rats of the SD strain weighing 150-180 g were used (10 animals per group). A pouch was formed by injecting 20 ml of N2 gas subcutaneously into the back. One milliliter of 1% croton oil dissolved in sesame oil was injected into the pouch. On the 8th day of the injection, the animals were sacrificed and the wet weight of the pouch and the exudate were measured. The adrenal glands, thymus, spleen, kidney and liver were also weighed immediately after extirpation, and expressed as weight per 100 g body weight. Test samples were administered orally at 24-h intervals for 8 d.
Statistics Student's 1-test was employed to assess the significance of differences between the mean valuesfor the control group and the sample-administered groups.
Results
Effect of Compds. 1-3 and 11-3 on the First Phase of Inflammation Vascular Permeability Test Using Mouse Ear As shown in Table I , compd. 1-3 significantly inhibited the increase of vascular permeability caused by xylene at a dose of 25 mg/kg p.o. On the other hand, the same dose of compd. II-3 had no effect. Phenylbutazone, used as a reference control, caused significant inhibition at 150 mg/kg p.o.
Capillary Permeability Test with Various Phlogists in Rat Skin
The effects of compds. 1-3 and 11-3 on capillary permeability are summarized in Table II . Compound 1-3 significantly depressed the increase in capillary permeability induced by bradykinin at a dose of 25 mg/kg p.o., but compd. 11-3 did not. Neither affected the increase of permeability induced by PG E2 (Table II) , histamine, serotonin or compound 48/80 (data not shown). Phenylbutazone inhibited the increase in the permeability induced by bradykinin and PG E2 at 200 mg/kg p.o. The inhibitory effect of phenylbutazone in the case of PG E2 may be explained by the fact that at such a high dose, phenylbutazone has membrane-stabilizing activity.5 '14) Ultraviolet Erythema in Guinea Pigs The inhibitory effect of compds. 1-3 and 11-3 on ultraviolet erythema is summarized in Table III . These compounds were administered intraperitoneally, because this inflammation model would not be influenced by the stimulating action of the administered sample.15 Compound 1-3 caused significant inhibition at a dose of 25 mg/kg i.p. at 2 and 5 h after the ultraviolet exposure, as did phenylbutazone at 50 mg/kg i.p., but compd. 11-3 had no effect.
Effect of Compds. 1-3 and 11-3 on the Second Phase of Inflammation CMC Granuloma Pouch The inhibitory activity of compds. 1-3 and 11-3 on leucocyte emigration to the pouch fluid is summarized in Table IV . When compared with the control, a significantly lower leucocyte number was observed at 4 h (or 6 h) after the CMC injection in the compd. 1-3 (or II-3)-administered group at a dose of 25 mg/kg p.o. On the other hand, neither compound affected vascular permeability measured in terms of the protein concentration in the exudate (Table V) inhibited granuloma formation in the felt pellet method as a subacute inflammatory model (Table VI) . Phenylbutazone significantly inhibited granuloma formation at a dose of 200 mg/kg. Various organs of rats from each group were weighed and the results are summarized in Table VII . Injection of compd. 1-3 had no effect on the organ weight, while compd. 11-3 (10 mg/kg) caused kidney atrophy. In the group given phenylbutazone, the weights of the adrenal glands and liver were increased.
Croton Oil Granuloma Pouch Method This test was employed as a subacute inflammatory model which is not responsive to non-steroidal anti-inflammatory drugs. At a daily dose of 25 mg/kg for 8 d, compds. 1-3 and 11-3 both significantly suppressed granuloma formation in the granuloma pouch method (Table VIII) . However, the exudate accumulation was not suppressed significantly by either compound. Phenylbutazone also inhibited granuloma formation. The thymus weight was found to be increased, and kidney weight, was decreased by the administration of compd. 11-3. The thymus weight was decreased and the liver weight was increased by the administration by phenylbutazone (Table IX) .
Discussion
In general, the inflammatory process can be divided into 3 phases. During the first phase, tissue damage caused by local stimulants and an enhancement of the vascular permeability take place. In the second phase, the emigration of leucocytes is observed. The third phase is characterized by granuloma formation and a regeneration of tissue. Since the inflammatory process involves many factors, the effectiveness of an anti-inflammatory drug should be evaluated by investigating the protective action in various inflammation models.
In this paper, we examined the effects of compds. 1-3 and 11-3 on 6 kinds of experimental models involving the 3 inflammation phases. Compound 1-3 possessed a wide antiinflammatory spectrum in the inflammation models used in the present study. From the results of the capillary permeability test in rats and the ultraviolet erythema test in guinea pigs, compd. 1-3 was considered to suppress the arachidonic acid cascade. The reasons are as follows. 1) Compound 1-3 inhibited the reaction caused by bradykinin, but did not compete with PG E2. It was reported that bradykinin stimulates PG synthesis and acts in combination with the PGs generated in the inflammatory process.16) 2) Non-steroidal anti-inflammatory drugs suppress the ultraviolet erythema via their inhibition of cyclooxygenase activity.') 3) Compound 1-3 had no effect on the direct actions of histamine, serotonin and compound 48/80. Also, it was not a strong inhibitor of the third phase of inflammation and did not cause adrenal atrophy, in contrast to the steroid hormone.
On the other hand, compd. 11-3 had a narrower anti-inflammatory spectrum than compd. 1-3. This compound was inhibitory in 3 models (CMC pouch, felt pellet and croton oil granuloma pouch methods). However, successive administration had the serious drawbacks of causing spleen and thymus hypertrophy and kidney atrophy. The pathological examination of tissue slices of rats given compd. 11-3 revealed abnormal arrangements of spleen and thymus cells, and glomerulonephritis in a few animals (data not shown). However, compd. 1-3 did not cause such damage. Compound 11-3 might affect the immune system and metabolic functions. The LD50 values of compds. 1-3 and 11-3 were more than 2.5 g/kg, i.p. and 770 mg/kg, i.p. in mice, respectively.
It is possible that compds. 1-3 and 11-3 are both converted into the corresponding thiol compounds after administration, analogously to SA-96 and penicillamine. SA-96 inhibited arthritis, but not the early phase of inflammation.") On the other hand, compds. 1-3 and 11-3 inhibited the early phase of inflammation, but not arthritis (data not shown). Thus, compd. I-3 is a new compound with a wide anti-inflammatory spectrum and low toxicity.
